HBIO is glad to announce that its president, Dr Andreas Persidis, has been included in the Top 100 AI Leaders in Drug Discovery and Advanced Healthcare list, as reported in a recent article by Deep Knowledge Ventures.
The DKI report which "aims to provide a “bird’s view” on the global leadership scene in the area of adopting ML/AI-driven methods in drug discovery and healthcare", presents the TOP 100 most innovative and entrepreneurial AI leaders, who have contributed to the data-driven transformation of the pharmaceutical and healthcare industries.
Inclusion on the list was based on the cumulative impact of each person on the advancement of the AI technologies in the pharmaceutical research (basic biology research, drug discovery and development, drug repurposing etc), and healthcare research (diagnostics, medical data management, therapy prescription etc).
More information and a link to download the report is available at
https://www.ai-pharma.dka.global/ai-leaders